{"nct_id":"NCT01309412","title":"A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2014-05","start_date":"2011-01","start_date_type":null,"primary_completion_date":"2012-12","primary_completion_date_type":"ACTUAL","completion_date":"2012-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}